Annual ROE
-89.48%
-22.93%-34.46%
December 31, 2023
Summary
- As of February 8, 2025, ALGS annual return on equity is -89.48%, with the most recent change of -22.93% (-34.46%) on December 31, 2023.
- During the last 3 years, ALGS annual ROE has fallen by -40.15% (-81.39%).
- ALGS annual ROE is now -211.10% below its all-time high of 80.54%, reached on December 31, 2019.
Performance
ALGS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-118.75%
-8.53%-7.74%
September 30, 2024
Summary
- As of February 8, 2025, ALGS quarterly return on equity is -118.75%, with the most recent change of -8.53% (-7.74%) on September 30, 2024.
- Over the past year, ALGS quarterly ROE has dropped by -10.55% (-9.75%).
- ALGS quarterly ROE is now -134.13% below its all-time high of 347.89%, reached on September 30, 2020.
Performance
ALGS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ALGS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.5% | -9.8% |
| 3 y3 years | -81.4% | -71.0% |
| 5 y5 years | - | -71.0% |
ALGS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -41.1% | at low | -82.5% | +13.9% |
| 5 y | 5-year | -211.1% | at low | -134.1% | +53.6% |
| alltime | all time | -211.1% | at low | -134.1% | +53.6% |
Aligos Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -118.75%(+7.7%) |
| Jun 2024 | - | -110.22%(-20.1%) |
| Mar 2024 | - | -137.90%(+27.4%) |
| Dec 2023 | -89.48%(+34.5%) | -108.20%(+15.3%) |
| Sep 2023 | - | -93.85%(+18.0%) |
| Jun 2023 | - | -79.51%(+14.5%) |
| Mar 2023 | - | -69.43%(+1.3%) |
| Dec 2022 | -66.55% | -68.55%(-0.3%) |
| Sep 2022 | - | -68.75%(-6.4%) |
| Jun 2022 | - | -73.43%(-1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -74.16%(+14.0%) |
| Dec 2021 | -63.41%(+28.5%) | -65.08%(+4.2%) |
| Sep 2021 | - | -62.43%(-44.2%) |
| Jun 2021 | - | -111.92%(-3.5%) |
| Mar 2021 | - | -116.03%(-26.8%) |
| Dec 2020 | -49.33%(-161.2%) | -158.59%(-145.6%) |
| Sep 2020 | - | 347.89%(-235.9%) |
| Jun 2020 | - | -256.05%(-417.9%) |
| Mar 2020 | - | 80.54%(+62.1%) |
| Dec 2019 | 80.54% | 49.68% |
FAQ
- What is Aligos Therapeutics annual return on equity?
- What is the all time high annual ROE for Aligos Therapeutics?
- What is Aligos Therapeutics annual ROE year-on-year change?
- What is Aligos Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Aligos Therapeutics?
- What is Aligos Therapeutics quarterly ROE year-on-year change?
What is Aligos Therapeutics annual return on equity?
The current annual ROE of ALGS is -89.48%
What is the all time high annual ROE for Aligos Therapeutics?
Aligos Therapeutics all-time high annual return on equity is 80.54%
What is Aligos Therapeutics annual ROE year-on-year change?
Over the past year, ALGS annual return on equity has changed by -22.93% (-34.46%)
What is Aligos Therapeutics quarterly return on equity?
The current quarterly ROE of ALGS is -118.75%
What is the all time high quarterly ROE for Aligos Therapeutics?
Aligos Therapeutics all-time high quarterly return on equity is 347.89%
What is Aligos Therapeutics quarterly ROE year-on-year change?
Over the past year, ALGS quarterly return on equity has changed by -10.55% (-9.75%)